This study examines the potential benefits of aspirin as adjuvant therapy for survivors of early breast cancer.
Among women living at least 1 year after a breast cancer diagnosis, aspirin use was associated with a decreased risk of distant recurrence and breast cancer death.
The Alliance trial led by Chen and colleagues and published in this issue of JAMA addresses an important topic in the management of breast cancer: can
Objectives Aspirin is an anti-inflammatory drug commonly used as an analgesic and in cardiovascular disorders. However, many studies have highlighted its anti-cancer properties, especially in color...
We investigated the associations of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) with breast cancer risk by the status of COX-2 protein expression. This study included 421 cases...
Purpose Animal and in vitro studies suggest that aspirin may inhibit breast cancer metastasis. We studied whether aspirin use among women with breast cancer decrease...
inhibition of nuclear factor-κB-mediated signals. This review synthesizes the evidence on the COX-2-independent mechanisms of action of aspirin, salicylates, and other NSAIDs on breast cancer.
regular aspirin use on breast cancer risks, but the results remain inconsistent. Here, we... Scopus, and Google Scholar from January 1939 to December 2019. Relative risk (RR) estimates were...
Acetyl salicyclic acid (aspirin) improves synthesis of maspin and lowers incidence of metastasis in breast cancer patients
To provide further human data, we examined the association between aspirin use and cancer... 93), lung cancer 0.68 (0.49–0.94), breast cancer in women 0.70 (0.50–0.96), and colorectal...